Laminar Completes CLINGLIO Trial Enrollment for LAM561
MALLORCA, Spain, July 23, 2026 Laminar Pharmaceuticals S.A. has announced the successful completion of patient recruitment for the CLINGLIO...
glioblastoma
Advertisement
GSK Seeks EMA Approval for Bexsero Booster Vaccine Update
LONDON, United Kingdom, July 20, 2026 GSK plc has announced that the European Medicines Agency (EMA) has accepted its...
BioLineRx to Present GLIX1 Ovarian Cancer Data at ESMO 2026
TEL AVIV, Israel & OSLO, Norway, July 20, 2026 BioLineRx Ltd. and Hemispherian AS have announced that new preclinical...
IN8bio Publishes Positive Phase 1 GBM Data
NEW YORK, July 9, 2026 IN8bio announced the publication of peer-reviewed Phase 1 clinical trial results for its investigational...
Northwest Biotherapeutics to Present DCVax-L Survival Analysis at BNOS 2026
BETHESDA, Md., July 2, 2026 Northwest Biotherapeutics announced that its Chief Technical Officer, Dr. Marnix Bosch, will deliver a...
Advertisements
CraniUS Secures NIH Grant for Glioblastoma Therapy
BALTIMORE, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of Health...
Siren Biotechnology Secures $8M CIRM Grant for SRN-101 Trial
SAN FRANCISCO, Calif., June 26, 2026 Siren Biotechnology has been awarded an $8 million non-dilutive CLIN2 grant from the...
Knoa Pharma and GCAR Expand Glioblastoma Trial Efforts
STAMFORD, Conn., June 24, 2026 Knoa Pharma LLC and the Global Coalition for Adaptive Research (GCAR) announced a significant...
Novocure Reports Phase 3 TRIDENT Trial Results
BAAR, Switzerland | June 18, 2026 Novocure has announced topline results from its Phase 3 TRIDENT trial, which evaluated...
NeOnc Expands International Clinical Development of NEO212 for Glioblastoma
CALABASAS, Calif., June 16, 2026 NeOnc Technologies Holdings, Inc. announced that the Department of Health – Abu Dhabi (DOH)...
Advertisement
